Raphas Co

Raphas Co Equity

The The Equity of Raphas Co (214260.KQ) as of Oct 31, 2026 is 28.33 B KRW. In the previous year, The Equity was 29.36 B KRW — a change of -3.51% (lower).

Equity

28.33 BKRW

YoY

-3.51%

Last updated:

In 2025, Raphas Co's equity was 28.33 B KRW, a -3.51% increase from the 29.36 B KRW equity in the previous year.

The Raphas Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
20.13 B KRW
Jan 1, 2019
47.83 B KRW
Jan 1, 2020
44.18 B KRW
Jan 1, 2021
52.36 B KRW
Jan 1, 2022
40.93 B KRW
Jan 1, 2023
29.54 B KRW
Jan 1, 2024
29.36 B KRW
Jan 1, 2025
28.33 B KRW
The Raphas Co Equity history
YEAREquityYoY
28.33 BKRW-3.51%
29.36 BKRW-0.61%
29.54 BKRW-27.82%
40.93 BKRW-21.83%
52.36 BKRW+18.51%
44.18 BKRW-7.63%
47.83 BKRW+137.59%
20.13 BKRW-15.21%
23.74 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Raphas Co Stock analysis

What does Raphas Co do? Raphas Co Ltd, headquartered in Seoul, South Korea, operates in the Consumer Staples sector within the Consumer Products industry. The company develops and sells cosmetics, pharmaceutical patches, and health functional foods under the Acropass brand, utilizing microstructure technology. Listed on 11 November 2019, Raphas focuses on innovative skincare and wellness solutions through its microarray patch research and development. Raphas Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Raphas Co's Equity

Raphas Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Raphas Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Raphas Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Raphas Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Raphas Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Raphas Co stock

The Equity of Raphas Co is 28.33 B KRW in 2025.

The Equity of Raphas Co changed from 29.36 B KRW to 28.33 B KRW, representing a -3.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Raphas Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Raphas Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Raphas Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Raphas Co